{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:48:20Z","timestamp":1790725700359,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005283","name":"FUNCAP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.micpath.2020.104365","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:41:35Z","timestamp":1593546095000},"page":"104365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease"],"prefix":"10.1016","volume":"148","author":[{"given":"Emanuelle Machado","family":"Marinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Batista de Andrade Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-858X","authenticated-orcid":false,"given":"Jacilene","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Rocha da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Coelho","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-8775","authenticated-orcid":false,"given":"Emmanuel Silva","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio Vitoriano","family":"Nobre J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104365_bib1","first-page":"12","article-title":"Coronavirus ( COVID-19 ): A review of clinical features","author":"Hassan","year":"2020","journal-title":"Diagnosis , and Treatment"},{"key":"10.1016\/j.micpath.2020.104365_bib2","author":"Nicola","year":"2020"},{"key":"10.1016\/j.micpath.2020.104365_bib3","series-title":"COVID-19 Diagnosis and Management\u00a0: a Comprehensive Review","first-page":"1","author":"Pascarella","year":"2020"},{"key":"10.1016\/j.micpath.2020.104365_bib4","author":"Jr","year":"2020"},{"key":"10.1016\/j.micpath.2020.104365_bib5","author":"Kandeel","year":"2020"},{"key":"10.1016\/j.micpath.2020.104365_bib6","first-page":"2020","article-title":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors","author":"Jin","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.micpath.2020.104365_bib7","series-title":"Estudos de Docking Molecular de Derivados da Tiazolidina Como Potenciais Inibidores da Enzima Cruza\u00edna de Trypanosoma cruzi","author":"Guerra","year":"2019"},{"key":"10.1016\/j.micpath.2020.104365_bib8","series-title":"Methylcytisine Alcaloid Potentially Active against Dengue Virus: A Molecular Docking Study and Electronic Structural Characterization","author":"Lucio","year":"2020"},{"key":"10.1016\/j.micpath.2020.104365_bib9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/14756366.2019.1666836","article-title":"Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies","volume":"34","author":"Milite","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"17","key":"10.1016\/j.micpath.2020.104365_bib10","first-page":"520","volume":"11","author":"Halgren","year":"2000","journal-title":"Merck Molecular Force Field"},{"key":"10.1016\/j.micpath.2020.104365_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2018.1564045","article-title":"Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida \u00e2-carbonic anhydrase enzyme","author":"Akdemir","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.micpath.2020.104365_bib12","author":"Hanwell"},{"key":"10.1016\/j.micpath.2020.104365_bib13","author":"Trott"},{"key":"10.1016\/j.micpath.2020.104365_bib14","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027829","article-title":"Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication","author":"Gurung","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.micpath.2020.104365_bib15","article-title":"DASSAULT syst\u00e8mes BIOVIA, discovery Studio visualizer","volume":"16.1.0","year":"2019","journal-title":"Vers\u00e3o"},{"key":"10.1016\/j.micpath.2020.104365_bib16","author":"Pettersen"},{"key":"10.1016\/j.micpath.2020.104365_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3410953","article-title":"Identification of bioactive compounds and analysis of inhibitory potential of the digestive enzymes from syzygium sp. Extracts","author":"Cavat\u00e3o De Freitas","year":"2019","journal-title":"J. Chem."},{"key":"10.1016\/j.micpath.2020.104365_bib18","series-title":"An Alternative Method for the Evaluation of Docking Performance","first-page":"1411","author":"Yusuf","year":"2008"},{"key":"10.1016\/j.micpath.2020.104365_bib19","first-page":"23","article-title":"In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter","volume":"7","author":"Shityakov","year":"2014","journal-title":"Adv. Appl. Bioinforma. Chem."},{"key":"10.1016\/j.micpath.2020.104365_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S0969-2126(02)00828-6","article-title":"C-H\u22efO hydrogen bonds in the nuclear receptor RAR\u03b3 - a potential tool for drug selectivity","author":"Klaholz","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.micpath.2020.104365_bib21","first-page":"1","article-title":"Characterization of hydrogen bonding: from van der waals interactions to covalency: unified picture of hydrogen bonding based on electron density topography analysis","author":"Parthasarathi","year":"2006","journal-title":"Hydrog. Bond. - New Insights"},{"key":"10.1016\/j.micpath.2020.104365_bib22","series-title":"An Introduction to Hydrogen Bonding","first-page":"1997","author":"Jeffrey","year":"1997"},{"key":"10.1016\/j.micpath.2020.104365_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U","article-title":"The hydrogen bond in the solid state","author":"Steiner","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.micpath.2020.104365_bib24","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.bmc.2012.02.057","article-title":"Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization","volume":"20","author":"Prakasham","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2020.104365_bib25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bmc.2013.12.067","article-title":"Synthesis of neolignans as microtubule stabilisers","volume":"22","author":"Sathish Kumar","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2020.104365_bib26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejmech.2014.09.033","article-title":"Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as antibreast cancer agents through microtubule stabilization","volume":"86","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2020.104365_bib27","first-page":"433","article-title":"The role of hydrogen-bonds in drug binding","volume":"289","author":"Wade","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.micpath.2020.104365_bib28","series-title":"Mol. Model. Predict. Bioactivity.","article-title":"Hydrogen bond contributions to properties and activities of chemicals and drugs","author":"Raevsky","year":"2000"},{"key":"10.1016\/j.micpath.2020.104365_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104365_bib30","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2020.104365_bib31","article-title":"Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact","volume":"S0163\u20134453","author":"Cantini F","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.micpath.2020.104365_bib32","first-page":"1","article-title":"Current pharmacological treatments for COVID-19: what's next?","author":"Scavone","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.micpath.2020.104365_bib33","series-title":"BRAZIL. Ministry of Health. Secretariat of Science, Technology, INFORMATION NOTE No. 5\/2020-DAF \/ SCTIE \/ MS","first-page":"1","year":"2020"},{"key":"10.1016\/j.micpath.2020.104365_bib34","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"20","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2020.104365_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0262-4079(20)30525-X","article-title":"The hunt for covid-19 drugs.pdf","volume":"245","author":"MacKenzie","year":"2020","journal-title":"New Sci."},{"key":"10.1016\/j.micpath.2020.104365_bib36","article-title":"Energetics based modeling of hydroxychloroquine and azithromycin binding to the SARS-CoV-2 spike (S)protein - ACE2 complex","author":"Sandeep","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.micpath.2020.104365_bib37","first-page":"2020","article-title":"Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study","author":"Lane","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.micpath.2020.104365_bib38","first-page":"2020","article-title":"Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb cl","author":"Borba","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.micpath.2020.104365_bib39","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1128\/JVI.02569-09","article-title":"Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs","volume":"84","author":"Gasparian","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2020.104365_bib40","first-page":"1","article-title":"Comer JE, freiberg AN, madrid PB, repurposing quinacrine against Ebola virus infection in vivo thomas","volume":"63","author":"Lane Tr","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104365_bib41","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"325","author":"Martin Re","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.micpath.2020.104365_bib42","first-page":"1","article-title":"Lysosomal adaptation: how cells respond to lysosomotropic compounds","volume":"12","author":"Lu","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2020.104365_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2020.104365_bib44","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/jac\/dkw222","article-title":"Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium","volume":"71","author":"Porter","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2020.104365_bib45","first-page":"1","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state","volume":"12203","author":"Rosenberg","year":"2020","journal-title":"JAMA, J. Am. Med. Assoc."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020307312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020307312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:34:44Z","timestamp":1760110484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020307312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"alternative-id":["S0882401020307312"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104365","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104365"}}